PFBT
PTCT icon

Parkside Financial Bank & Trust’s PTC Therapeutics PTCT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.04K Hold
74
– – ﹤0.01% 1819
2025
Q4 		$5.62K Buy
74
+15
+25% +$1.09K ﹤0.01% 1764
2025
Q3 		$3.62K Sell
59
-7
-11% -$365 ﹤0.01% 1828
2025
Q2 		$3.22K Buy
66
+26
+65% +$1.23K ﹤0.01% 1847
2025
Q1 		$2.04K Buy
+40
New +$2K ﹤0.01% 1881

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Parkside Financial Bank & Trust's PTCT Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its PTC Therapeutics (PTCT) position steady in Q1 2026 at 74 shares worth $5.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1819.

Parkside Financial Bank & Trust first reported a position in PTCT in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.62K in Q4 2025. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Parkside Financial Bank & Trust held 74 shares of PTC Therapeutics worth $5.04K as of Q1 2026.
  • Parkside Financial Bank & Trust left its PTC Therapeutics share count unchanged in Q1 2026.
  • PTC Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1819 holding.
  • Parkside Financial Bank & Trust first reported a position in PTC Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's PTC Therapeutics position peaked at $5.62K in Q4 2025.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.